TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: patient overall rating of disease status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severe disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transcutaneous partial pressure of carbon dioxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: level of residual symptoms after drug discontinuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean AHI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: fasting fractional GNG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fasting GNG flux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tolerance to EGD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bronchial hyper-responsiveness (BHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Positive skin prick test (SPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anti-asthmatic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: improvement in asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: decline in corticosteroid dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relief of nasal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional burden of catheter use
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Practical burden of catheter use
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Learners' satisfaction with HFS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rapid viral response (RVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of negative facial expressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative recall of positive emotional material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective ratings of hostility
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Median reduction in seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Responder rate (> 50% reduction in seizures)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Mortality from metastatic cancer
Endpoint domain: Mortality/survival
Primary endpoint: Survival free of local recurrence at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Survival free of local progression
Endpoint domain: Mortality/survival
Primary endpoint: EPA and DHA status (% of total plasma phospholipids)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma carotenoid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: pain scores at rest and movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: central nervous system side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Disease-related deaths
Endpoint domain: Mortality/survival
Primary endpoint: reduced mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Participation rates in education sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participation rates in medication reviews
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participation rates in evaluation meetings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Somatomotor community structure consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of second-order connections between somatomotor cortex and insular cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak MET capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in CL/F and V(d)/F
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in F
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Altered K(a)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen partial pressure in arterial blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDA levels in blood plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: XO enzymatic activity in colonic mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median SF concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: improvement in subclinical hepatic encephalopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean visual analogue scale scores for cough
Endpoint domain: Adverse events/effects
Primary endpoint: Change in BNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: satisfactory to excellent pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal respiratory support
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of nausea and vomiting in the postoperative period
Endpoint domain: Adverse events/effects
Primary endpoint: Mean requirement of rescue antiemetic
Endpoint domain: Adverse events/effects
Primary endpoint: Patient satisfaction after 24 hours of surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postimmunization geometric mean titers (GMTs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of detectable hepatitis C RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: incidence of tourniquet pain
Endpoint domain: Adverse events/effects
Primary endpoint: time required for complete neural blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk for death or major disability at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Pathological downstaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tumour size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Average volume of water consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: otalgia improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oedema improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tenderness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of Event Scale‐Revised scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression Scale‐Severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative MRI T2 relaxation values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean and median survival time
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in severity of pregnancy-related low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of back pain on sleeping
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Use of analgesic medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: central aortic pulse pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: total cardiovascular events/procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: development of renal impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Periodontal attachment improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in bleeding tendency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eradication of pathogenic bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: postoperative recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Motivation to complete a clinical trial
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: abnormal microvascular function parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Body composition changes (lean mass and fat mass)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CNS adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: incident diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ED visits related to CVD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: listener comprehension accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPD-free survival to discharge
Endpoint domain: Mortality/survival
Primary endpoint: Rate of infants requiring O2 at 28 d of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MODS (Multiple Organ Dysfunction Syndrome)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lesser stigmatizing attitude towards individuals with mental illness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Implantation rate per embryo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage of goal LDL-C levels achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average decrease in LDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Identification of new or worsening clinical problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child need for educational and mental health services
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in CD4+ count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of germ and Sertoli cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of arrhythmic heartbeats
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heat sensation after CM injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of > 4 vomiting episodes
Endpoint domain: Adverse events/effects
Primary endpoint: number of parturients requiring rescue antiemetics
Endpoint domain: Adverse events/effects
Primary endpoint: attenuation of retroactive memory interference effect
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Surgical field visibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: eosinophilic cationic protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: serum total protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nocturnal slow wave sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subfoveal choroidal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: iPTH reductions of ≥30% from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Perceived Stress Scale (PSS-14) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: lung deposition prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: total daily amount of amikacin urinary excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: in vivo drug output rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: response rate
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Mean percentage improvement in HAQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically meaningful improvement in HAQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in physical and mental component summary (PCS and MCS) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient comfort during procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful cannulation within 3 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of jugular vein cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CO-confirmed abstinence rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute grade 2 diarrhoea frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Time to return to work (RTW) sustained for ≥4 weeks
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total sickness absence during the 12-month follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maximum SNR enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to maximum SNR enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Subjective image quality score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day total length of stay (LOS)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Coronary thrombotic event
Endpoint domain: Adverse events/effects
Primary endpoint: Presence or absence of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with follow-up appointments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ΔCIMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: calculated CHD risk reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Central corneal thickness (CT) measurement agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease of perfusion defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: increase of total work performed during bicycle exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decline of intramyocardial tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnosis of pre-eclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mean number of acid reflux episodes of >5 minutes duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hepatic inflammatory necrosis activity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Hepatic fibrosis degree improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Colon cleansing outcome (BBPS and ABPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RRT-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: catecholamine-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Practice recruitment rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Marginal adaptation (integrity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KOOS categories improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tegner activity level score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved adherence to antihypertensive medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MCV levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Recurrence-free survival at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: three-month progression-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Increase in the use of thoracic radiotherapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: lipoprotein profile alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HDL function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: time-to-progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical functioning scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: TNFalpha levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to transfer to peripheral ward
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to brain metastasis (BM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Role-emotional
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Heart failure symptoms (NYHA class)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: neck flexion improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: initiation of breast feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Bone loss from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: median total operating time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Vo(2)max improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of fungal infection
Endpoint domain: Adverse events/effects
Primary endpoint: Abnormal Gd-DTPA enhancement of sacroiliac joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of TBM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of treatment with MF‐Hp
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Overall Survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: PTP(di)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: f/V(T)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: TT(di)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of mGFRs outside 30% of reference mGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Hypometabolism in the cingulate gyrus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Border irregularity parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean distance walked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No smokeless tobacco use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients able to reach the targeted CD34+ cell dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of mobilization failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility and acceptability of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Healing rate of incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Posterior instability
Endpoint domain: Adverse events/effects
Primary endpoint: Achievement scores in reading
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Achievement scores in mathematics
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: IL-1 beta production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Symptomatic atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improvements in eating disorders (ED) symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scarring improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of amplitude N1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median VAS at 18 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes